Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: The HELIUS study

Sexually Transmitted Infections

Volumn 92, Issue 8, 2016, Pages 611-618

  Alberts, C J ^a,b   Vos, R A ^a   Borgdorff, H ^b,c   Vermeulen, W ^a   Van Bergen, J ^d,e   Bruisten, S M ^a,b   Geerlings, S E ^b   Snijder, M B ^e   Van Houdt, R ^f   Morre S A ^f,g   De Vries, H J C ^b,h   Van De Wijgert, J H H M ^b,c,i   Prins, M ^a,b   Schim Van Der Loeff, M F ^a,b  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

^c AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^d National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Epidemiology (General); Ethnicity; HPV; Women

Indexed keywords

ADULT; AFRICAN; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUTCHMAN; ETHNICITY; FEMALE; GHANAIAN; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NETHERLANDS; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEXUAL BEHAVIOR; SOUTH ASIAN; SURINAMESE; TURK (PEOPLE); YOUNG ADULT; ADOLESCENT; EARLY CANCER DIAGNOSIS; EDUCATIONAL STATUS; ETHNIC GROUP; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; VAGINA; VIROLOGY;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; HUMANS; NETHERLANDS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS; VAGINA; YOUNG ADULT;

EID: 84969921054     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2015-052397     Document Type: Article

References (33)

1. GLOBOCAN database, (database on the Internet). IARC. 2012. http://globocan.iarc. fr (01-07-2015, date last accessed). 1-7-2015.
2. Azerkan F, Zendehdel K, Tillgren P, et al. Risk of cervical cancer among immigrants by age at immigration and follow-up time in Sweden, from 1968 to 2004. Int J Cancer 2008;123:2664-70.
3. Watson M, Saraiya M, Wu X. Update of HPV-associated female genital cancers in the United States, 1999-2004. J Womens Health (Larchmt) 2009;18:1731-8.
4. Visser O, Busquet EH, van Leeuwen FE, et al. [Incidence of cervical cancer in women in North-Holland by country of birth from 1988-1998]. Ned Tijdschr Geneeskd 2003;147:70-4.
5. Arnold M, Aarts MJ, van der Aa M, et al. Investigating cervical, oesophageal and colon cancer risk and survival among migrants in The Netherlands. Eur J Public Health 2013;23:867-73.
6. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(Suppl 1):S1-15.
7. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20-8.
8. Burk RD, Ho GY, Beardsley L, et al. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 1996;174:679-89.
9. Moscicki AB, Palefsky J, Gonzales J, et al. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr Res 1990;28:507-13.
10. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56.
11. van Leeuwen AW, de Nooijer P, Hop WC. Screening for cervical carcinoma. Cancer 2005;105:270-6.
12. Banister CE, Messersmith AR, Chakraborty H, et al. HPV prevalence at enrollment and baseline results from the Carolina Women's Care Study, a longitudinal study of HPV persistence in women of college age. Int J Womens Health 2013;5: 379-88.
13. Vidal AC, Smith JS, Valea F, et al. HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. Cancer Causes Control 2014;25:1055-62.
14. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8.
15. Banister CE, Messersmith AR, Cai B, et al. Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J Infect Dis 2015;211:100-8.
16. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008;26(Suppl 10):K1-16.
17. Statistics Netherlands [Centraal Bureau voor Statistiek]. 2015. http://statline.cbs.nl/Statweb
18. Kramer M, Mollema L, Smits G, et al. Age-specific HPV seroprevalence among young females in The Netherlands. Sex Transm Infect 2010;86:494-9.
19. Heiligenberg M, Michael KM, Kramer MA, et al. Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam. Sex Transm Dis 2010;37:672-80.
20. Gök M, Heideman DA, van Kemenade FJ, et al. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders. Eur J Cancer 2012;48:1799-808.
21. Stronks K, Snijder MB, Peters RJ, et al. Unravelling the impact of ethnicity on health in Europe: the HELIUS study. BMC Public Health 2013;13:402.
22. Stronks K, Kulu-Glasgow I, Agyemang C. The utility of 'country of birth' for the classification of ethnic groups in health research: the Dutch experience. Ethn Health 2009;14:255-69.
23. Molijn A, Kleter B, Quint W, et al. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005;32(Suppl 1):S43-51.
24. van Aar F, Mooij SH, van der Sande MA, et al. Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM. AIDS 2013;27:2921-31.
25. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009;10:321-2.
26. Xue X, Gange SJ, Zhong Y, et al. Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev 2010;19:159-69.
27. Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015;372: 711-23.
28. Food and Drug Administration. Highlights of prescribing information. Gardasil 9 (human papillomavirus nonvalent [types 6, 11, 16, 18, 31, 33, 45, 52, and 58]). Silver Spring, MD: US Department of Health and Human Services; Food and Drug Administration, 2014. http://www.fda.gov (accessed 8-7-2015).
29. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 2015;107: 86.
30. Lenselink CH, Melchers WJ, Quint WG, et al. Sexual behaviour and HPV infections in 18 to 29-year-old women in the pre-vaccine era in the Netherlands. PLoS ONE 2008;3:e3743.
31. Winer RL, Feng Q, Hughes JP, et al. Risk of female human papillomavirus acquisition associated with first Male sex partner. J Infect Dis 2008;197:279-82.
32. Volksgezondheidenzorg database, 2015, Sexual Behaviour, Young adults 12-24 years of age. http://volksgezondheidenzorg.info, RIVM: Bilthoven, (01-07-2015, date last accessed). 2015.10-7-2015.
33. Coupé VMH, Berkhof J, Bulkmans NWJ, et al. Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening. Br J Cancer 2008;98:646-51.